Trending News

Changes to Civil Rights Enforcement: New Executive Order Eliminates Disparate-Impact Liability in Federal Regulations

How Are Family Offices Building Smarter Wealth? Structural Alpha (11 Examples)

DOJ Rule Restricting Sensitive Data Transfers Takes Effect

The Trump Administration’s Diversity, Equity, and Inclusion (DEI) Executive Orders: A Brief Primer

Trump Administration Announces "Reciprocal" Tariffs

What Every Multinational Company Should Know About … The Global and Reciprocal Tariffs Announcement

Blockading the Ports: U.S. Imposes 10% Global Tariff; Higher Reciprocal Tariff Rates by Country

Fifth Circuit Court of Appeals Negates Ruling on Federal Contractor Minimum Wage

New Executive Order Rescinds the $17.75 Per Hour Federal Contractor Minimum Wage

Medicare Telehealth Gets Another Temporary Lifeline – Will Congress Make it Permanent?

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Lisata Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
Posted On Thursday, February 27, 2025
Mustang Bio Announces Sale of Fixed Assets and Exit of Facility
Posted On Thursday, February 27, 2025
Pacira BioSciences Reports Fourth Quarter and Full-Year 2024 Financial Results
Posted On Thursday, February 27, 2025
89bio Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates
Posted On Thursday, February 27, 2025
Organogenesis Holdings Inc. Reports Fourth Quarter 2024 Financial Results
Posted On Thursday, February 27, 2025
TELA Bio to Announce Fourth Quarter and Full Year 2024 Financial Results
Posted On Thursday, February 27, 2025
Seer Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Outlook
Posted On Thursday, February 27, 2025
Athira Pharma Reports Full Year 2024 Financial Results and Pipeline and Business Updates
Posted On Thursday, February 27, 2025
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2024 Financial Results
Posted On Thursday, February 27, 2025
Zhittya Genesis Medicine Announces: Landmark fMRI Study Reveals 21.2% Boost in Brain Blood Flow in Parkinson’s Patient Following Six Months of Intranasal FGF-1 Therapy
Posted On Thursday, February 27, 2025
BioCardia Announces Primary Outcome Measures Data Freeze in CardiAMP Heart Failure Trial for Presentation at the American College of Cardiology 2025 Scientific Sessions
Posted On Thursday, February 27, 2025
Amarin Marks Key Milestone for VASCEPA®/VAZKEPA® (Icosapent Ethyl) -- Publication of Post Hoc Analysis of REDUCE-IT in Journal of the American Heart Association Reports Benefit on Top of Cholesterol Lowering
Posted On Thursday, February 27, 2025
New York Blood Center Enterprises and Human Life CORD Sign Letter of Intent to Expand Manufacturing Collaboration for Umbilical Cord -Derived Mesenchymal Stromal Cells
Posted On Thursday, February 27, 2025
Precision Neuroscience Expands Clinical Research in Brain–Computer Interface Through Collaboration with Beth Israel Deaconess Medical Center
Posted On Thursday, February 27, 2025
Ocugen, Inc. Announces FDA Alignment on Phase 2/3 Pivotal Confirmatory Clinical Trial for Modifier Gene Therapy Candidate OCU410ST for Stargardt Disease
Posted On Thursday, February 27, 2025
Supernus to Participate in the TD Cowen 45th Annual Health Care Conference
Posted On Thursday, February 27, 2025
IMUNON Reports 2024 Financial Results and Provides Business Update Highlighting Significant Progress Towards the Initiation of a Pivotal Phase 3 Study
Posted On Thursday, February 27, 2025
Frontier Medicines to Participate in Two Upcoming March Investor Conferences
Posted On Thursday, February 27, 2025
Jasper Therapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Corporate Update
Posted On Thursday, February 27, 2025
Humacyte Announces Issuance of U.S. Patent Covering Manufacturing of Symvess™ and Other Bioengineered Tissues
Posted On Thursday, February 27, 2025
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2024 Financial Results on March 13, 2025
Posted On Thursday, February 27, 2025
ALX Oncology to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025
Posted On Thursday, February 27, 2025
Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2024 Financial Results
Posted On Thursday, February 27, 2025
Windtree Files Istaroxime Cardiogenic Shock and Prevention of Arrythmias Patent for India
Posted On Thursday, February 27, 2025
electroCore, Inc. Announces Agreement with Spark Biomedical Inc. to Distribute Sparrow Ascent for Opioid Withdrawal
Posted On Thursday, February 27, 2025

Print